DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 -17.27 -0.34%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo

Celgene (NASDAQ: CELG)

118.82 -0.70 (-0.59%)

REAL-TIME: Last trade at

Extended Hours: $118.60 -$0.22 (-0.19%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

CELG $118.82 -0.59%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $118.42
Previous Close $119.52
Daily Range $117.90 - $120.34
52-Week Range $82.90 - $129.06
Market Cap $94.2B
P/E Ratio 40.93
Dividend (Yield) $0.00 (0.0%)
Volume 3,508,367
Average Daily Volume 4,002,872
Current FY EPS $4.07

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

3 Biotech Stocks Working On CAR-T Immunotherapy You Ought To Watch

Juno Therapeutics, Kite Pharma, and Ziopharm Oncology are developing an entirely new way to battle cancer.

Celgene's Move Into Merck's Former Campus Signals Next Stage Of Growth

Benitec And Bluebird Bio, Gene Therapy Coming Of Age?

Can Celgene Corporation's Superior Earnings Growth Continue?

Celgene has grown earnings far faster than revenue over the past several years. Can they keep it up, or are margins set to peak?

3 Biotech Stocks That Could Grow Faster than Apple

Apple is the king to which all other stocks are compared. However, these three biotech stocks could be poised to trump the tech giant's phenomenal growth rate.

Sector's Smaller Players Show The Way

A $1 Billion Bet on Cancer Cures

Celgene hands $1 Billion to Juno Therapeutics and health insurance on the exchanges will climb 4.4% next year.

Blame the E.U.; Don't Ignore the Good News; ... But Stay Skeptical: Jim Cramer's Best Blogs

Multiple Observations On Celgene's Latest Licensing Deals, And Its Valuation

Seeking Alpha's Biotech Weekly: Celgene-Juno, Gilead's HIV NDA, Happy 4th!

See More CELG News...

CELG's Top Competitors

CELG $118.82 (-0.59%)
Current stock: CELG
AMGN $154.50 (0.81%)
Current stock: AMGN
GILD $115.66 (0.54%)
Current stock: GILD
$0.00 (0.00%)
Current stock: